Form 4: Merck Director Inge G. Thulin Reports Transaction in Phantom Stock

Director Inge G. Thulin reports acquisition of phantom stock units convertible to cash based on Merck's common stock value.

Summary

• Inge G. Thulin, a director of Merck & Co., Inc., filed a Form 4 on June 4, 2024, reporting a transaction.
• The transaction involved the acquisition of 1,752.4295 units of phantom stock on May 31, 2024.
• These phantom stock units are to be settled in cash upon the director's termination of service, according to a pre-determined distribution schedule.
• The price of the underlying common stock at the time of the transaction was $125.54.
• Following the reported transaction, Thulin beneficially owns 21,228.9219 derivative securities (phantom stock).
• Holdings include shares acquired in dividend reinvestment transactions.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.

Future Outlook

The phantom stock units will be settled in cash upon the director's termination of service, according to a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

Industry Context

Form 4 filings are standard practice for reporting transactions by company insiders, providing transparency to investors.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.

Key Dates